Outcomes of Ahmed Glaucoma Valve Implantation With Viscoelastic Fill at Both Beginning and End of Surgery.
Dugan Connor, Zheng Cindy X, Lin Michael M, Ustaoglu Melih, Zhang Qiang Ed, Hamershock Rose A, Moster Stephen J, Moster Marlene R
AI Summary
Studying Ahmed valve surgery, early viscoelastic injection did not reduce short-term complications like hypotony or shallow ACs, suggesting no clinical benefit for this modified technique.
Abstract
Unlabelled: PRéCIS:: Intracameral injection of viscoelastic at the beginning of Ahmed FP7 implantation did not reduce early postoperative complication rates.
Purpose
To evaluate early postoperative complication rates after a modified technique in which the anterior chamber (AC) is filled with viscoelastic at the beginning of Ahmed FP7 implantation before conjunctival peritomy.
Subjects and methods
A retrospective chart review was performed of eyes that underwent Ahmed FP7 implantation with or without viscoelastic fill to ~20 mm Hg by finger tension by a single surgeon (M.R.M). Viscoelastic prevented the AC from becoming shallow at any time during surgery, and additional viscoelastic was injected into the AC at the end of surgery to achieve a final intraocular pressure (IOP) of 20 mm Hg.
Results
A total of 159 eyes of 159 patients were included. Mean age was 76.4±10.4 years. Mean preoperative IOP was 30.3±9.7 mm Hg on 2.7±1.2 glaucoma medications. On postoperative day 1, there was an IOP spike ≥30 mm Hg in 0% of patients. Within the first postoperative month, hypotony (<5 mm Hg) occurred in 19 (21.8%) eyes that received viscoelastic fill compared with 5 (13.2%) eyes that did not receive viscoelastic fill (P=0.26). During the early postoperative period (≤3 mo), there was no difference in AC depth, microhyphema, choroidal effusion, or leakage between the 2 groups (P≥0.30 for all). There was a higher rate of layered hyphemas in the viscoelastic-fill group at postoperative week 1 (P=0.01). At 3-month follow-up, mean IOP was 14.9±5.5 mm Hg on 1.6±0.8 medications in the viscoelastic-fill group and 16.0±5.2 mm Hg on 1.0±1.2 medications in the nonviscoelastic-fill group (IOP P=0.35). Compared with baseline, change in IOP at 3 months was similar between both groups (P=0.15). Rates of additional medications and procedures did not differ between the 2 groups at any postoperative visit.
Conclusions
Early intracameral injection of viscoelastic during Ahmed glaucoma valve implantation did not reduce early postoperative complication rates.
MeSH Terms
Shields Classification
Key Concepts5
Intracameral injection of viscoelastic at the beginning of Ahmed FP7 implantation did not reduce early postoperative complication rates.
Within the first postoperative month, hypotony (<5 mm Hg) occurred in 19 (21.8%) eyes that received viscoelastic fill during Ahmed FP7 implantation compared with 5 (13.2%) eyes that did not receive viscoelastic fill (P=0.26).
During the early postoperative period (≤3 mo) after Ahmed FP7 implantation, there was no difference in anterior chamber depth, microhyphema, choroidal effusion, or leakage between eyes that received viscoelastic fill and those that did not (P≥0.30 for all).
There was a higher rate of layered hyphemas in the viscoelastic-fill group at postoperative week 1 (P=0.01) following Ahmed FP7 implantation.
At 3-month follow-up, mean intraocular pressure (IOP) after Ahmed FP7 implantation was 14.9±5.5 mm Hg on 1.6±0.8 medications in the viscoelastic-fill group and 16.0±5.2 mm Hg on 1.0±1.2 medications in the nonviscoelastic-fill group (IOP P=0.35).
Related Articles5
The Paul Glaucoma Implant: a systematic review of safety, efficacy, and emerging applications.
Systematic ReviewLong-term comparative outcomes of Hydrus versus iStent inject microinvasive glaucoma surgery implants combined with cataract surgery.
Observational StudySpecial Commentary: Reporting Clinical Endpoints in Studies of Minimally Invasive Glaucoma Surgery.
ReviewTwo-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry.
Observational StudyThe use of intraluminal PRESERFLO stenting in avoiding early postoperative hypotony.
Observational StudyIs this article assigned to the wrong chapter(s)? Let us know.